Drug
Ndi 5001
Ndi 5001: highest development phase Phase 1, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| NDI-5001 NCT07525960 | Phase 1 | Diabetes Insipidus |
Latest
No recent events.
Follow Ndi 5001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.